Onset of severe perianal disease in Crohn's disease under treatment with infliximab: successful treatment with adalimumab and setons drainage.
Tursi
Antonio
A
Papa
Alfredo
A
Maiorano
Michele
M
D000068879:Adalimumab; D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001004:Anus Diseases / Q000188:drug therapy* / Q000209:etiology*; D003424:Crohn Disease / Q000150:complications*; D004322:Drainage; D005260:Female; D006801:Humans; D000069285:Infliximab; D010502:Perineum / Q000473:pathology*; D012003:Rectal Fistula / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab